Aurinia Pharm Ord (AUPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 283,055 | 235,133 | 175,513 | 134,030 | 45,605 |
| Cost of Goods | 32,665 | 28,248 | 14,148 | 5,664 | 1,091 |
| Gross Profit | 250,390 | 206,885 | 161,365 | 128,366 | 44,514 |
| Operating Expenses | 136,611 | 216,167 | 244,825 | 242,023 | 224,766 |
| Operating Income | 114,444 | -9,034 | -83,312 | -112,993 | -180,161 |
| Interest Expense | 4,330 | 4,835 | 2,775 | 0 | 0 |
| Other Income | 4,043 | 21,317 | 8,618 | 6,641 | -45 |
| Pre-tax Income | 114,157 | 7,448 | -77,469 | -106,352 | -180,206 |
| Income Tax | -173,045 | 1,696 | 551 | 1,828 | 760 |
| Net Income Continuous | 287,202 | 5,752 | -78,020 | -108,180 | -180,966 |
| Net Income | $287,202 | $5,752 | $-78,020 | $-108,180 | $-180,966 |
| EPS Basic Total Ops | 2.14 | 0.04 | -0.54 | -0.76 | -1.40 |
| EPS Basic Continuous Ops | 2.14 | 0.04 | -0.54 | -0.76 | -1.40 |
| EPS Diluted Total Ops | 2.07 | 0.04 | -0.54 | -0.76 | -1.40 |
| EPS Diluted Continuous Ops | 2.07 | 0.04 | -0.54 | -0.76 | -1.40 |
| EPS Diluted Before Non-Recurring Items | 0.82 | 0.16 | -0.54 | -0.76 | -1.40 |
| EBITDA(a) | $133,893 | $10,411 | $-71,665 | $-110,287 | $-177,400 |